Amodiaquine as the first-line treatment of malaria in Yaounde, Cameroon: Presumptive evidence from activity in vitro and cross-resistance patterns

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 2, 1998, Pages 212-213

  Ringwald, Pascal ^a,b   Bickii, Jean ^a   Basco, Leonardo K ^a  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^b Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

Author keywords

Amodiaquine; Cameroon; Chemotherapy; Malaria; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; CHLOROQUINE; DEETHYLAMODIAQUINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CAMEROON; CROSS RESISTANCE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 0031943729     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)90752-0     Document Type: Article

References (14)

1. Basco, L. K. & Le Bras, J. (1993). In vitro activities of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 48, 120-125.
2. Bickii, J., Basco, L. K. & Ringwald, P. (in press). Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. Journal of Clinical Microbiology.
3. Desjardins, R. E., Canfield, C. J., Haynes, J. D. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710-718.
4. Hawley, S. R., Bray, P. G., Park, B. K. & Ward, S. A. (1996). Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Molecular and Biochemical Parasitology, 80, 15-25.
5. Louis, J. P., Hengy, C., Louis, F. J., Gazin, P., Jambou, R., Gardon, J., Fadat, G. & Trebucq, A. (1992). Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon. Tropical Medicine and Parasitology, 43, 118-120.
6. Nevill, C. G., Verhoeff, F. H., Munafu, C. G., Ten Hove, W. R., Van der Kaay, H. J. & Were, J. B. O. (1994). A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya. East African Medical Journal, 71, 167-170.
7. Olliaro, P. L. & Trigg, P. I. (1995). Status of antimalarial drugs under development. Bulletin of the World Health Organization, 73, 565-571.
8. Olliaro, P. L., Nevill, C., Le Bras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196-1201.
9. Radloff, P. D., Philipps, J., Nkeyi, M., Hutchinson, D. & Kremsner, P. G. (1996). Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet, 347, 1511-1514.
10. Ringwald, P., Bickii, J. & Basco, L. K. (1996a). Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet, 347, 24-28.
11. Ringwald, P., Bickii, J. & Basco, L. K. (1996b). In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. American Journal of Tropical Medicine and Hygiene, 55, 254-258.
12. Turaman, C., Basco, L. K. & Le Bras, J. (1992). Evaluation of therapeutic efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by simplified in vivo test. Bulletin of the World Health Organization, 70, 477-480.
13. WHO (1990a). Practical Chemotherapy of Malaria. Geneva: World Health Organization, Technical Report Series, no. 805.
14. WHO (1990b). Severe and complicated malaria, 2nd edition. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.